NCT06949254View on ClinicalTrials.gov

PRospective Observational Study of STereotactic Body rAdiation Therapy With Androgen Deprivation Therapy for Organ-confined High-risk Prostate Cancer: the PROSTAR Trial

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

April 4, 2025

Primary Completion Date

May 31, 2032

Study Completion Date

May 31, 2032

Conditions

High Risk Prostate Cancer

Trial Locations (3)

20089

RECRUITING

IRCCS Humanitas Research Hospital, Rozzano

20159

NOT_YET_RECRUITING

Humanitas PIO X, Milan

24125

NOT_YET_RECRUITING

Humanitas Gavazzeni, Bergamo

All Listed Sponsors

collaborator

accord healthcare italia srl

UNKNOWN

lead

Istituto Clinico Humanitas

OTHER

NCT06949254 - PRospective Observational Study of STereotactic Body rAdiation Therapy With Androgen Deprivation Therapy for Organ-confined High-risk Prostate Cancer: the PROSTAR Trial | Biotech Hunter | Biotech Hunter